Resultados da pesquisa - Schlamm, Haran T
- A mostrar 1 - 11 resultados de 11
-
1
-
2
Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidi... Por Kett, Daniel H, Shorr, Andrew F, Reboli, Annette C, Reisman, Arlene L, Biswas, Pinaki, Schlamm, Haran T
Publicado em 2011Text -
3
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associate... Por Reboli, Annette C, Shorr, Andrew F, Rotstein, Coleman, Pappas, Peter G, Kett, Daniel H, Schlamm, Haran T, Reisman, Arlene L, Biswas, Pinaki, Walsh, Thomas J
Publicado em 2011Text -
4
Pharmacokinetics, Safety, and Tolerability of Voriconazole in Immunocompromised Children Por Walsh, Thomas J., Driscoll, Timothy, Milligan, Peter A., Wood, Nolan D., Schlamm, Haran, Groll, Andreas H., Jafri, Hasan, Arrieta, Antonio C., Klein, Nigel J., Lutsar, Irja
Publicado em 2010Text -
5
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation Por Marks, David I, Pagliuca, Antonio, Kibbler, Christopher C, Glasmacher, Axel, Heussel, Claus-Peter, Kantecki, Michal, Miller, Paul JS, Ribaud, Patricia, Schlamm, Haran T, Solano, Carlos, Cook, Gordon
Publicado em 2011Text -
6
Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis Por Chai, Louis Yi Ann, Kullberg, Bart Jan, Earnest, Arul, Johnson, Elizabeth M., Teerenstra, Steven, Vonk, Alieke G., Schlamm, Haran T., Herbrecht, Raoul, Netea, Mihai G., Troke, Peter F.
Publicado em 2014Text -
7
1157. Clinical Safety, Efficacy, and Pharmacokinetics of Fosmanogepix, a Novel First-in-class Antifungal, in Patients with Renal Insufficiency: Subset Analysis from a Phase 2 Candi... Por Bulpa, Pierre, Rahav, Galia, Oren, Ilana, Aoun, Mickaël, Thompson, George R, Pappas, Peter, Kullberg, Bart Jan, Vazquez, Jose A, Barbat, Sara, Wedel, Pamela, Schlamm, Haran T, Hodges, Michael
Publicado em 2020Text -
8
Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials Por Kullberg, Bart Jan, Vasquez, José, Mootsikapun, Piroon, Nucci, Marcio, Paiva, José-Artur, Garbino, Jorge, Yan, Jean Li, Aram, Jalal, Capparella, Maria Rita, Conte, Umberto, Schlamm, Haran, Swanson, Robert, Herbrecht, Raoul
Publicado em 2017Text -
9
Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis Por Chai, Louis Y. A., Kullberg, Bart-Jan, Johnson, Elizabeth M., Teerenstra, Steven, Khin, Lay Wai, Vonk, Alieke G., Maertens, Johan, Lortholary, Olivier, Donnelly, Peter J., Schlamm, Haran T., Troke, Peter F., Netea, Mihai G., Herbrecht, Raoul
Publicado em 2012Text -
10
Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant reci... Por Bow, Eric J, Vanness, David J, Slavin, Monica, Cordonnier, Catherine, Cornely, Oliver A, Marks, David I, Pagliuca, Antonio, Solano, Carlos, Cragin, Lael, Shaul, Alissa J, Sorensen, Sonja, Chambers, Richard, Kantecki, Michal, Weinstein, David, Schlamm, Haran
Publicado em 2015Text -
11
147. Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial Por Pappas, Peter, Kullberg, Bart Jan, Vazquez, Jose A, Oren, Ilana, Rahav, Galia, Aoun, Mickaël, Bulpa, Pierre, Ben-Ami, Ronen, Ferrer, Ricard, McCarty, Todd P, Thompson III, George R, Barbat, Sara, Wedel, Pamela, Oborska, Iwonka, Schlamm, Haran T, Hodges, Michael
Publicado em 2020Text